ARCH Venture Fund XII, L.P. on City Therapeutics, Inc., Oct 26, 2026

ARCH Venture Fund XII, L.P. now owns 25.6%. It has said it may push for changes.

Date
Oct 26, 2026
Who
ARCH Venture Fund XII, L.P.
Fund
City Therapeutics
Stake
25.6% (13,692,507 shares)
Type of notice
May push for changes
Document number
0001193125-26-432028

Open the original document at the SEC →

We read this document automatically. If something looks wrong, the original is the one that counts.

Back to City Therapeutics